Literature DB >> 24240682

MicroRNAs and cancer stem cells: the sword and the shield.

X Sun1, X Jiao2, T G Pestell3, C Fan4, S Qin5, E Mirabelli2, H Ren6, R G Pestell2.   

Abstract

Emerging chemotherapy drugs and targeted therapies have been widely applied in anticancer treatment and have given oncologists a promising future. Nevertheless, regeneration and recurrence are still huge obstacles on the way to cure cancer. Cancer stem cells (CSCs) are capable of self-renewal, tumor initiation, recurrence, metastasis, therapy resistance, and reside as a subset in many, if not all, cancers. Therefore, therapeutics specifically targeting and killing CSCs are being identified, and may be promising and effective strategies to eliminate cancer. MicroRNAs (miRNAs, miRs), small noncoding RNAs regulating gene expression in a post-transcriptional manner, are dysregulated in most malignancies and are identified as important regulators of CSCs. However, limited knowledge exists for biological and molecular mechanism by which miRNAs regulate CSCs. In this article, we review CSCs, miRNAs and the interactions between miRNA regulation and CSCs, with a specific focus on the molecular mechanisms and clinical applications. This review will help us to know in detail how CSCs are regulated by miRNAs networks and also help to develop more effective and secure miRNA-based clinical therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240682     DOI: 10.1038/onc.2013.492

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  65 in total

Review 1.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

2.  MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7.

Authors:  Rui Liang; Yuan Li; Meng Wang; Shou-Ching Tang; Guodong Xiao; Xin Sun; Gang Li; Ning Du; Dapeng Liu; Hong Ren
Journal:  Cell Cycle       Date:  2018-07-14       Impact factor: 4.534

3.  Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.

Authors:  Amit K Srivastava; Ananya Banerjee; Tiantian Cui; Chunhua Han; Shurui Cai; Lu Liu; Dayong Wu; Ri Cui; Zaibo Li; Xiaoli Zhang; Guozhen Xie; Karuppaiyah Selvendiran; Srinivas Patnaik; Adam R Karpf; Jinsong Liu; David E Cohn; Qi-En Wang
Journal:  Cancer Res       Date:  2019-03-20       Impact factor: 12.701

4.  Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.

Authors:  Shusuke Toden; Shigeyasu Kunitoshi; Jacob Cardenas; Jinghua Gu; Elizabeth Hutchins; Kendall Van Keuren-Jensen; Hiroyuki Uetake; Yuji Toiyama; Ajay Goel
Journal:  JCI Insight       Date:  2019-03-21

5.  FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.

Authors:  Guodong Xiao; Yuan Li; Meng Wang; Xiang Li; Sida Qin; Xin Sun; Rui Liang; Boxiang Zhang; Ning Du; Chongwen Xu; Hong Ren; Dapeng Liu
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

6.  miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.

Authors:  Guodong Xiao; Boxiang Zhang; Jinying Meng; Jichang Wang; Chongwen Xu; Shou-Ching Tang; Xiang Li; Jing Zhang; Rui Liang; Hong Ren; Xin Sun
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

7.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

8.  ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.

Authors:  Cody L Nesvick; Chao Zhang; Nancy A Edwards; Blake K Montgomery; Michaela Lee; Chunzhang Yang; Herui Wang; Dongwang Zhu; John D Heiss; Marsha J Merrill; Abhik Ray-Chaudhury; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

Review 9.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20

Review 10.  Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges.

Authors:  A C Birkeland; J H Owen; M E Prince
Journal:  J Dent Res       Date:  2015-08-25       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.